TrialBone marrow transplantation2019

Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma.

Khadega A Abuelgasim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.